Guardian Connect is the world\u2019s first Smart Continuous Glucose Monitoring System connected with smartphone displays for real-time data viewing of glucose levels, without a separate hardware monitor. In a first of its kind collaborative initiative in India between a pharmaceutical and medical device company, Eris Lifesciences and India Medtronic Pvt. Ltd, a wholly owned subsidiary of Medtronic plc , has announced their collaboration for a diabetes monitoring initiative in India. The two companies will utilise their respective strengths in helping patients monitor their diabetes better. Medtronic will bring to India its latest US FDA approved Guardian Connect device for real-time evaluation of glucose variability in diabetes patients. Eris through its national reach will provide the device at clinics and healthcare delivery units under its patient care initiative.<\/p>\n
Commenting on the development, Amit Bakshi, Chairman and Managing Director, Eris Lifesciences said, \u201cFor better patient outcomes in diabetes, we believe that a holistic approach of medicine, diet and continuous monitoring is important. Technology has emerged as a great enabler in healthcare. While technology is transforming healthcare delivery, on the patient and physician end there is a need to create more awareness of how to use technology and how technology can make managing diabetes easier. Through this initiative, we aim to make patients and physicians adopt newer technologies for better health.\u201d<\/p>\n
Describing the benefits of the collaboration, Madan Krishnan, Managing Director & Vice President, India Medtronic Pvt. Ltd., said, \u201cMedtronic\u2019s innovations in the space of Continuous Glucose Monitoring and Insulin Pumps has transformed diabetes management. Guardian Connect is a technological breakthrough that will change the diabetes treatment landscape. It empowers the patient to take control in real-time and the physician to be fully-equipped with data and evidence. In a large country like India, with high incidence of diabetes, we are happy to align with a partner who understands the challenges of diabetes management and has the reach to take our solutions across the country.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"
Guardian Connect is the world\u2019s first Smart Continuous Glucose Monitoring System connected with smartphone displays for real-time data viewing of glucose levels, without a separate hardware monitor. In a first of its kind collaborative initiative in India between a pharmaceutical and medical device company, Eris Lifesciences and India Medtronic Pvt. Ltd, a wholly owned subsidiary […]<\/p>\n","protected":false},"author":3,"featured_media":3325,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[80],"tags":[3068,778,3067,137],"class_list":["post-3324","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-brands-lifestyle","tag-glucose-levels","tag-healthcare","tag-smart-continuous-glucose-monitoring-system","tag-smartphone"],"aioseo_notices":[],"yoast_head":"\n